David Verbel
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 4
- Prostate Cancer Diagnosis and Treatment 3
- Gastric Cancer Management and Outcomes 2
- Oncology 6
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Howard I. Scher (11 shared papers)Carlos Cordon‐Cardo (7 shared papers)William Kevin Kelly (5 shared papers)Glenn Heller (5 shared papers)Olivier Saidi (6 shared papers)Michael J. Morris (4 shared papers)Angeliki Kotsianti (5 shared papers)Mikhail Teverovskiy (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Alzheimer s & Dementia (2 papers)Alzheimer s Research & Therapy (2 papers)Urology (2 papers)Cancer (2 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
David Verbel
42 papers receiving 3.3k citations
David Verbel's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 707
- Pulmonary and Respiratory Medicine 835
- Radiology, Nuclear Medicine and Imaging 402
- Cancer Research 252
- Molecular Biology 1.2k
Countries citing papers authored by David Verbel
This map shows the geographic impact of David Verbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Verbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Verbel more than expected).
Fields of papers citing papers by David Verbel
This network shows the impact of papers produced by David Verbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Verbel. The network helps show where David Verbel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Verbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. | 2002 | 373 |
| 2 | 2002 | 330 | |
| 3 | 2007 | 306 | |
| 4 | 2004 | 279 | |
| 5 | 2002 | 224 | |
| 6 | 2003 | 224 | |
| 7 | 2002 | 154 | |
| 8 | 2003 | 151 | |
| 9 | HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. | 2001 | 138 |
| 10 | 2002 | 120 | |
| 11 | 2001 | 105 | |
| 12 | 2005 | 102 | |
| 13 | 2007 | 96 | |
| 14 | 2005 | 95 | |
| 15 | 2002 | 94 | |
| 16 | 2022 | 88 | |
| 17 | Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid Hit paper breakdown → | 2024 | 74 |
| 18 | p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. | 2003 | 61 |
| 19 | 2014 | 53 | |
| 20 | 2005 | 36 |
About David Verbel
David Verbel is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Statistics and Probability, Physiology and Artificial Intelligence, having authored 43 papers that have together received 3.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Prostate Cancer Treatment and Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Alzheimer's disease research and treatments (3 papers), AI in cancer detection (3 papers), Statistical Methods in Clinical Trials (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (707 citations), Pulmonary and Respiratory Medicine (835 citations), Radiology, Nuclear Medicine and Imaging (402 citations), Cancer Research (252 citations) and Molecular Biology (1.2k citations). David Verbel has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Howard I. Scher, Carlos Cordon‐Cardo, William Kevin Kelly, Glenn Heller, Olivier Saidi, Michael J. Morris, Angeliki Kotsianti, Mikhail Teverovskiy, Ho-Yuen Pang and Ali Tabesh. Their work appears in journals such as Journal of Clinical Oncology, Alzheimer s & Dementia, Alzheimer s Research & Therapy, Urology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.